These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18321879)

  • 1. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.
    Gamiel JL; Tobian AA; Laeyendecker OB; Reynolds SJ; Morrow RA; Serwadda D; Gray RH; Quinn TC
    Clin Vaccine Immunol; 2008 May; 15(5):888-90. PubMed ID: 18321879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.
    Laeyendecker O; Henson C; Gray RH; Nguyen RH; Horne BJ; Wawer MJ; Serwadda D; Kiwanuka N; Morrow RA; Hogrefe W; Quinn TC
    J Clin Microbiol; 2004 Apr; 42(4):1794-6. PubMed ID: 15071053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
    Nascimento MC; Ferreira S; Sabino E; Hamilton I; Parry J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.
    LeGoff J; Mayaud P; Gresenguet G; Weiss HA; Nzambi K; Frost E; Pepin J; Belec L;
    J Clin Microbiol; 2008 Jun; 46(6):1914-8. PubMed ID: 18385443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
    Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
    Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
    Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
    Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
    Morrow RA; Friedrich D; Meier A; Corey L
    BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.
    Biraro S; Mayaud P; Morrow RA; Grosskurth H; Weiss HA
    Sex Transm Dis; 2011 Feb; 38(2):140-7. PubMed ID: 20706175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.
    Lingappa J; Nakku-Joloba E; Magaret A; Friedrich D; Dragavon J; Kambugu F; Joloba M; Whalen C; Coombs R; Celum C; Morrow RA
    Int J STD AIDS; 2010 Sep; 21(9):611-6. PubMed ID: 21097732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China.
    Ngo TD; Laeyendecker O; Morrow RA; Lai S; Quinn TC
    Clin Vaccine Immunol; 2008 Aug; 15(8):1301-3. PubMed ID: 18508932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of HSV-2 type specific serological tests in men in Kenya.
    Ng'ayo MO; Friedrich D; Holmes KK; Bukusi E; Morrow RA
    J Virol Methods; 2010 Feb; 163(2):276-81. PubMed ID: 19854222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
    Ashley-Morrow R; Nollkamper J; Robinson NJ; Bishop N; Smith J
    Clin Microbiol Infect; 2004 Jun; 10(6):530-6. PubMed ID: 15191381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory.
    Turner KR; Wong EH; Kent CK; Klausner JD
    Sex Transm Dis; 2002 Jul; 29(7):422-5. PubMed ID: 12170133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics.
    Summerton J; Riedesel M; Laeyendecker O; Gaydos C; Maldeis NE; Hardick A; Morrow RA; Quinn TC
    Clin Vaccine Immunol; 2007 Dec; 14(12):1545-9. PubMed ID: 17913866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.
    Patel EU; Manucci J; Kahle EM; Lingappa JR; Morrow RA; Piwowar-Manning E; James A; Maluzi KF; Cheeba MM; Gray G; Kosloff B; Delany-Moretlwe S; Inambao M; Vwalika B; Quinn TC; Laeyendecker O
    BMC Infect Dis; 2015 Sep; 15():398. PubMed ID: 26423888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies.
    Reddy SM; Balakrishnan P; Uma S; Thyagarajan SP; Solomon S
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):359-60. PubMed ID: 15699434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of four diagnostic assays for detecting herpes simplex virus type 2 antibodies in the Middle East and North Africa.
    Nasrallah GK; Dargham SR; Sahara AS; Elsidiq MS; Abu-Raddad LJ
    J Clin Virol; 2019 Feb; 111():33-38. PubMed ID: 30639845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes.
    Morrow RA; Friedrich D; Krantz E
    J Clin Microbiol; 2003 Nov; 41(11):5212-4. PubMed ID: 14605166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics.
    Ribes JA; Hayes M; Smith A; Winters JL; Baker DJ
    J Clin Microbiol; 2001 Oct; 39(10):3740-2. PubMed ID: 11574606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.
    Serwadda D; Gray RH; Sewankambo NK; Wabwire-Mangen F; Chen MZ; Quinn TC; Lutalo T; Kiwanuka N; Kigozi G; Nalugoda F; Meehan MP; Ashley Morrow R; Wawer MJ
    J Infect Dis; 2003 Nov; 188(10):1492-7. PubMed ID: 14624374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.